Efficacy of low dose urokinase combined with low molecular weight heparin sodium in the treatment of elderly patients with acute coronary syndrome

Studies have shown that low dose urokinase combined with low molecular weight heparin sodium in the treatment of elderly patients with acute coronary syndrome has a significant clinical effect, which is significantly better than the conventional treatment (beta blockers, calcium antagonists, nitrate esters, aspirin, clopidogrel, etc.).